50 Results for "

51224

" in MedChemExpress (MCE) Product Catalog:
Products (50)

50 Results for "51224" in MCE Product Catalog:

102
102 Publications Verification
Cat. No.: HY-12270
CAS No.: 530141-72-1
Purity:  99.03%
Target:  

AP-1 MMP

T-5224 is a transcription factor c-Fos/activator protein (AP)-1 inhibitor with anti-inflammatory effects, which specifically inhibits the DNA binding activity of c-Fos/c-Jun without affecting other transcription factors. T-5224 inhibits the IL-1β-induced up-regulation of Mmp-3, Mmp-13 and Adamts-5 transcription .
2
2 Cited Publications
Cat. No.: HY-109010
CAS No.: 1353552-97-2
Purity:  98.08%
Synonyms: HM71224; LY3337641
Research Areas:  

Metabolic Disease

Poseltinib (HM71224) is an orally active, selective, irreversible small molecule Bruton tyrosine kinase (BTK) inhibitor. With an IC50 of 1.95 nM. Poseltinib effectively inhibits the signaling mediated by B cell receptors (BCR), Fc receptors (FcR), and Toll-like receptors (TLR). Poseltinib has anti-inflammatory activity and can be used in the research of rheumatoid arthritis .
2
2 Cited Publications
Cat. No.: HY-15462
CAS No.: 1204707-71-0
Purity:  99.82%
Synonyms: AZD-5122
Target:  

CXCR

SRT3109 is an antagonist of CXCR2, with a pIC50 of 8.2, and used in the research of chemokine mediated diseases.
Cat. No.: HY-16779B
CAS No.: 914361-45-8
Synonyms: BMS-379224 L-lysine ethanolate; E-1224 L-lysine ethanolate
Target:  

Fungal Parasite

Research Areas:  

Infection

Fosravuconazole L-lysine ethanolate (BMS-379224 L-lysine ethanolate), a proagent of Ravuconazole, is an orally active broad spectrum antifungal agent. Fosravuconazole L-lysine ethanolate can be used for candidiasis, onychomycosis and parasitemia research .
Cat. No.: HY-16779
CAS No.: 351227-64-0
Synonyms: BMS-379224; E-1224
Target:  

Fungal Parasite

Research Areas:  

Infection

Fosravuconazole (BMS-379224), a proagent of Ravuconazole, is an orally active broad spectrum antifungal agent. Fosravuconazole can be used for candidiasis, onychomycosis and parasitemia research .
Cat. No.: HY-153386
CAS No.: 2891620-68-9
Purity:  99.83%
Research Areas:  

Cancer

CPD-1224 is an orally effective ALK inhibitor, a derivative of an ALK inhibitor that connects to the cereblon ligand. CPD-1224 targets the EML4-ALK oncogenic fusion protein and degrades both ALK and the mutant forms L1196M/G1202R. CPD-1224 can slow down tumor growth .
Cat. No.: HY-164927
CAS No.: 2417851-93-3
Target:  

Influenza Virus

Research Areas:  

Infection Inflammation/Immunology

AV5124, a prodrug of AV5116, is an orally active influenza virus cap-dependent endonuclease (CEN) endonuclease inhibitor .
Cat. No.: HY-R00113
Target:  

MicroRNA

Research Areas:  

Cancer

hsa-miR-1224-3p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.
Cat. No.: HY-12270R
CAS No.: 530141-72-1
Target:  

AP-1 MMP

Research Areas:  

Others

T-5224 (Standard) is the analytical standard of T-5224. This product is intended for research and analytical applications. T-5224 is a transcription factor c-Fos/activator protein (AP)-1 inhibitor with anti-inflammatory effects, which specifically inhibits the DNA binding activity of c-Fos/c-Jun without affecting other transcription factors. T-5224 inhibits the IL-1β-induced up-regulation of Mmp-3, Mmp-13 and Adamts-5 transcription .
Cat. No.: HY-138247
CAS No.: 2114651-20-4
Purity:  98.59%
Synonyms: EX-A4764; UUN51204
Research Areas:  

Infection

β-Lactamase-IN-2 is a beta-lactamase inhibitor, extracted from patent WO 2019075084 A1, compound 1. β-Lactamase-IN-2 has anti-microbial and anti-bacterial effects .
Cat. No.: HY-P990754
CAS No.: 2771389-44-5
Synonyms: M-1224

Target:  

c-Kit

Research Areas:  

Inflammation/Immunology

Opelkibart is an anti-KIT human IgG1 κ monoclonal antibody . Recommend Isotype Controls: Human IgG1 kappa, Isotype Control (HY-P99001).
Cat. No.: HY-123398
CAS No.: 69811-30-9
RS-51324 is an oral active antidepressant agent. RS-51324 inhibitts norepinephrine uptake and reverses of Reserpine (HY-N0480)-induced hypothermia .
Cat. No.: HY-19308
CAS No.: 205701-85-5
Target:  

GABA Receptor

Research Areas:  

Neurological Disease

RWJ-51204 is a partial agonist of GABA(A) receptor, with Ki of 0.2-2 nM to the benzodiazepine site on GABA(A) receptors.
Cat. No.: HY-131508
CAS No.: 15382-90-8
Target:  

Parasite

Research Areas:  

Infection

M&B 5124 is a potent inhibitor of Schistosoma mansoni in mice .
Cat. No.: HY-19862
CAS No.: 1614265-31-4
Research Areas:  

Cardiovascular Disease

TY-51924 ethanol sodium is a highly selective NHE-1 inhibitor (IC50 = 0.095 μM). TY-51924 ethanol sodium can significantly reduce the infarct size and myocardial enzyme release. TY-51924 ethanol sodium is commonly used in the study of ischemia-reperfusion injury .
Cat. No.: HY-R03266
Target:  

MicroRNA

Research Areas:  

Cancer

mmu-miR-5122 mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.
Cat. No.: HY-R03266A
Target:  

MicroRNA

Research Areas:  

Cancer

mmu-miR-5122 agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.
Cat. No.: HY-RI03266
Target:  

MicroRNA

Research Areas:  

Cancer

mmu-miR-5122 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.
Cat. No.: HY-R03268
Target:  

MicroRNA

Research Areas:  

Cancer

mmu-miR-5124a mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.
Cat. No.: HY-R03268A
Target:  

MicroRNA

Research Areas:  

Cancer

mmu-miR-5124a agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.